Actionable news
All posts from Actionable news
Actionable news in PTX: Pernix Therapeutics Holdings, Inc.,

Speculating On Pernix Therapeutics


Recent earning results have eroded the stock price by just over -80% YTD.

Active interest by management to explore strategic alternatives, including debt restructuring and potential sale of the company, should give investors solace.

Current price level justifies risk versus reward.

Buyout could be announced in the third or fourth quarter, at a minimum price target of $3.

The past two months have not been good for Pernix Therapeutics (NASDAQ:PTX). After missing fourth quarter earnings by nearly 59 times the estimate, the stock has seen a steady decline from around $2.25 to $0.46 as of the Wednesday, June 1st close. The first quarter...